Loftus DJ - Search Results

1

Private Spaceflight: A New Landscape for Dealing with Medical Risk.

Griko YV, Loftus DJ, Stolc V, Peletskaya E. Griko YV, et al. Among authors: loftus dj. Life Sci Space Res (Amst). 2022 May;33:41-47. doi: 10.1016/j.lssr.2022.03.001. Epub 2022 Mar 23. Life Sci Space Res (Amst). 2022. PMID: 35491028 Review.

2

NASA Radiation Biomarker Workshop, September 27-28, 2007.

Straume T, Amundson SA, Blakely WF, Burns FJ, Chen A, Dainiak N, Franklin S, Leary JA, Loftus DJ, Morgan WF, Pellmar TC, Stolc V, Turteltaub KW, Vaughan AT, Vijayakumar S, Wyrobek AJ. Straume T, et al. Among authors: loftus dj. Radiat Res. 2008 Sep;170(3):393-405. doi: 10.1667/RR1382.1. Radiat Res. 2008. PMID: 18763867

3

Morphological and chemical changes of aerosolized E. coli treated with a dielectric barrier discharge.

Romero-Mangado J, Nordlund D, Soberon F, Deane G, Maughan K, Sainio S, Singh G, Daniels S, Saunders IT, Loftus D, Meyyappan M, Koehne J, Gandhiraman RP. Romero-Mangado J, et al. Biointerphases. 2016 Mar 12;11(2):011009. doi: 10.1116/1.4941367. Biointerphases. 2016. PMID: 26872580

4

Shared oxidative pathways in response to gravity-dependent loading and gamma-irradiation of bone marrow-derived skeletal cell progenitors.

Kondo H, Limoli C, Searby ND, Almeida EA, Loftus DJ, Vercoutere W, Morey-Holton E, Giedzinski E, Mojarrab R, Hilton D, Globus RK. Kondo H, et al. Among authors: loftus dj. Radiats Biol Radioecol. 2007 May-Jun;47(3):281-5. Radiats Biol Radioecol. 2007. PMID: 17867495

5

The ability of variant peptides to reverse the nonresponsiveness of T lymphocytes to the wild-type sequence p53(264-272) epitope.

Hoffmann TK, Loftus DJ, Nakano K, Maeurer MJ, Chikamatsu K, Appella E, Whiteside TL, DeLeo AB. Hoffmann TK, et al. Among authors: loftus dj. J Immunol. 2002 Feb 1;168(3):1338-47. doi: 10.4049/jimmunol.168.3.1338. J Immunol. 2002. PMID: 11801674

6

Mutant cadherin affects epithelial morphogenesis and invasion, but not transformation.

Troxell ML, Loftus DJ, Nelson WJ, Marrs JA. Troxell ML, et al. Among authors: loftus dj. J Cell Sci. 2001 Mar;114(Pt 6):1237-46. doi: 10.1242/jcs.114.6.1237. J Cell Sci. 2001. PMID: 11228167

7

A superagonist variant of peptide MART1/Melan A27-35 elicits anti-melanoma CD8+ T cells with enhanced functional characteristics: implication for more effective immunotherapy.

Rivoltini L, Squarcina P, Loftus DJ, Castelli C, Tarsini P, Mazzocchi A, Rini F, Viggiano V, Belli F, Parmiani G. Rivoltini L, et al. Among authors: loftus dj. Cancer Res. 1999 Jan 15;59(2):301-6. Cancer Res. 1999. PMID: 9927036

8

Structural evidence of T cell xeno-reactivity in the absence of molecular mimicry.

Zhao R, Loftus DJ, Appella E, Collins EJ. Zhao R, et al. Among authors: loftus dj. J Exp Med. 1999 Jan 18;189(2):359-70. doi: 10.1084/jem.189.2.359. J Exp Med. 1999. PMID: 9892618 Free PMC article.

9

Peptides derived from self-proteins as partial agonists and antagonists of human CD8+ T-cell clones reactive to melanoma/melanocyte epitope MART1(27-35).

Loftus DJ, Squarcina P, Nielsen MB, Geisler C, Castelli C, Odum N, Appella E, Parmiani G, Rivoltini L. Loftus DJ, et al. Cancer Res. 1998 Jun 1;58(11):2433-9. Cancer Res. 1998. PMID: 9622085

10

Report of immune monitoring of prostate cancer patients undergoing T-cell therapy using dendritic cells pulsed with HLA-A2-specific peptides from prostate-specific membrane antigen (PSMA).

Salgaller ML, Lodge PA, McLean JG, Tjoa BA, Loftus DJ, Ragde H, Kenny GM, Rogers M, Boynton AL, Murphy GP. Salgaller ML, et al. Among authors: loftus dj. Prostate. 1998 May;35(2):144-51. doi: 10.1002/(sici)1097-0045(19980501)35:2<144::aid-pros8>3.0.co;2-j. Prostate. 1998. PMID: 9568678 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

25 results

Search Page